Could a booster shot protect newborns from deadly GBS infection?
NCT ID NCT06592586
First seen Jan 31, 2026 · Last updated Jun 08, 2026 · Updated 23 times
Summary
This study follows about 338 healthy pregnant women in Denmark and South Africa who previously received the GBS-NN/NN2 vaccine. Researchers want to see if the immune protection lasts and if a booster dose during a new pregnancy is safe and effective. The goal is to help prevent serious infections like sepsis, pneumonia, and meningitis in newborns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aarhus Universitetshospital
Aarhus N, Central Jutland, 8200, Denmark
-
Hvidovre Hospital - Department Of Obstetrics And Gynaecology
Copenhagen, Capital Region, 2650, Denmark
-
Sefako Makgatho Health Sciences University, Medunsa Clinical Research Unit (MeCRU)
Ga-Rankuwa, Gauteng, 0204, South Africa
-
Setshaba Research Centre
Pretoria, Guateng Province, 0152, South Africa
-
Sygehus Lillebælt - Kolding Sygehus
Kolding, Region Syddanmark, 6000, Denmark
-
Wits Reproductive Health and HIV Institute (Wits RHI)
Johannesburg, Guateng Province, 2001, South Africa
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.